Terms: = Bone cancer AND H3F3B, H3_3A, 3021, ENSG00000132475, P84243, H3_3B, MGC87783, MGC87782, H3F3
41 results:
1. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
[TBL] [Abstract] [Full Text] [Related]
2. Giant Cell Tumor of the Acromion: Case Report and Literature Review.
Sano J; Chijiiwa Y; Nishio J
In Vivo; 2024; 38(1):506-510. PubMed ID: 38148094
[TBL] [Abstract] [Full Text] [Related]
3. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
Rekhi B; Dave V; Butle A; Dutt A
Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
[TBL] [Abstract] [Full Text] [Related]
4. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.
Ono T; Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Akiyama T; Kojima N; Toda Y; Sato C; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2023 Sep; 36(5):1804-1812. PubMed ID: 37328637
[TBL] [Abstract] [Full Text] [Related]
5. Giant cell tumor of bone with h3f3b mutation: A case report.
Wu R; Wu X; Weng X; Xiu Y; Xu G; Liu X; Liu X
Medicine (Baltimore); 2023 Feb; 102(7):e32995. PubMed ID: 36800629
[TBL] [Abstract] [Full Text] [Related]
6. Chondroblastoma: clinicopathological analyses of 307 cases from a single institution in China and the diagnostic value of the h3f3 K36M mutant antibody.
Zhao Q; Tang J; Luo Y; Huang J; Hu D; Zhu J; Jiang T; Zhang H; Liu Z
J Clin Pathol; 2023 Jun; 76(6):367-373. PubMed ID: 36604179
[TBL] [Abstract] [Full Text] [Related]
7. Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma.
Toda Y; Yamamoto H; Iwasaki T; Ishihara S; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Kiyozawa D; Yamada Y; Kohashi K; Kimura A; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
Pathol Res Pract; 2023 Jan; 241():154239. PubMed ID: 36442415
[TBL] [Abstract] [Full Text] [Related]
8. Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with
Gu H; Sun L; Cui J; Yu L; Wang J
Fetal Pediatr Pathol; 2023 Apr; 42(2):320-326. PubMed ID: 36048092
[No Abstract] [Full Text] [Related]
9. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
[TBL] [Abstract] [Full Text] [Related]
10. Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone.
Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Fukushima S; Toda Y; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Sep; 35(5):1621-1629. PubMed ID: 35653034
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
Giesche J; Mellert K; Geißler S; Arndt S; Seeling C; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TF
J Pathol; 2022 Aug; 257(5):687-696. PubMed ID: 35522566
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic Utility of Genetic and Immunohistochemical
Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
[TBL] [Abstract] [Full Text] [Related]
13. Gene of the month: h3f3A and h3f3b.
Aldera AP; Govender D
J Clin Pathol; 2022 Jan; 75(1):1-4. PubMed ID: 34782425
[No Abstract] [Full Text] [Related]
14. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors.
Agaimy A; Michal M; Stoehr R; Ferrazzi F; Fabian P; Michal M; Franchi A; Haller F; Folpe AL; Kösemehmetoğlu K
Mod Pathol; 2021 Aug; 34(8):1507-1520. PubMed ID: 33742141
[TBL] [Abstract] [Full Text] [Related]
15. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
[TBL] [Abstract] [Full Text] [Related]
16. Histone Mutations and bone cancers.
Taylor EL; Westendorf JJ
Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
[TBL] [Abstract] [Full Text] [Related]
17. Drivers underpinning the malignant transformation of giant cell tumour of bone.
Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
[TBL] [Abstract] [Full Text] [Related]
19. Metastasizing chondroblastoma: a rare bone tumor no longer supported by the WHO classification.
Baumhoer D; Harder D; Ameline B; Dawson H; Kollar A
Skeletal Radiol; 2021 Jan; 50(1):255-260. PubMed ID: 32594198
[TBL] [Abstract] [Full Text] [Related]
20. Multiple primary tumors: a case report and review of the literature.
Zhao Z; Sun K; Yan T; Wei R; Guo W
BMC Musculoskelet Disord; 2020 Jun; 21(1):394. PubMed ID: 32571290
[TBL] [Abstract] [Full Text] [Related]
[Next]
